Multiple Sclerosis Study
NeuroTrials Research is conducting a research study to determine the efficacy of an investigational drug.
Qualified participants receive all study-related exams and study drug at no cost. Compensation is available for time and travel.
You may qualify if you:
•are 18-55.
•have been diagnosed with MS.
•have experienced either a worsening of MS
symptoms or new symptoms.
•do not have a diagnosis of primary progessive MS.
•have no other neurological disorders.
Click here for more info.
If you are interested in participating in this study, please CONTACT US.
Research for Parkinson's Disease
How can you help with Parkinson's Disease?
NeuroTrials Research is
conducting a study on the
efficacy of a new study drug
for patients with moderate to severe Parkinson’s Disease.
You may qualify if you:
•are 30 to 85
•are in general good health
•experience slowness in movement
•experience muscle rigidity or resting tremors
•have been receiving a stable dose of L-Dopa for over a year Click here for more info.
If you are interested in participating in this study, please CONTACT US.
COPD Study
NeuroTrials is currently enrolling for a variety of COPD studies. You may qualify if you:
•Have been diagnosed with moderate to severe Chronic Obstructive Pulmonary Disease (COPD)
•Are over 40
•Are a current or former smoker
Click here for more info.
If you are interested in participating in this study, please CONTACT US.
Do You Suffer From Epilepsy?
If you suffer from epilepsy, you may be eligible to participate in a clinical study of an investigational drug for partial onset seizures.
Qualified participants must be:
•17-65 years old
•Diagnosed with epilepsy for at least 1 year
•In overall good health
•Currently taking antiepileptic medication
Click here for more info
If you are interested in participating in this study, please CONTACT US.
Alzheimer's Research
NeuroTrials Research is conducting a 20-month, placebo-controlled research study evaluating an investigational drug for Alzheimer’s Disease.
Study-related exams and study drug are provided at no cost. Qualified participants & caregivers will be compensated for time and travel. To qualify, participants must:
-be 50-89 years of age.
-have a diagnosis of probable Alzheimer’s Disease.
-have a caregiver capable of attending all -study visits.
-otherwise be in general good health.
Click here for more info
If you are interested in participating in this study, please CONTACT US.
NEW! Restless Legs Syndrome
Writhing and Rolling from Restless Legs?
NeuroTrials Research is conducting a local study to examine the safety and efficacy of a new investigational drug for Restless Legs Syndrome.
You may qualify if you:
•are 18-70 years of age.
•have a history of RLS for over 6 months.
experience symptoms of RLS for at least 15 nights per month.
•are otherwise in good general health. Click here for more info.
If you are interested in participating in this study, please CONTACT US.
NEW! Narcolepsy Research
Wake up to NEW narcolepsy research!
NeuroTrials Research is conducting a new, 4-week study evaluating the safety and efficacy of an investigational drug for excessive daytime sleepiness in individuals with narcolepsy.
To qualify, you must:
•be 18-65
•have a diagnosis of narcolepsy
•be in general good health
•have a typical bedtime before midnight
Click here for more info.
If you are interested in participating in this study, please CONTACT US.
|